Sagimet Biosciences Inc. Marketable Securities, Current in USD from Q4 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Sagimet Biosciences Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2022 to Q3 2025.
  • Sagimet Biosciences Inc. Marketable Securities, Current for the quarter ending September 30, 2025 was $84.2M, a 11.6% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)

Sagimet Biosciences Inc. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $84.2M +$8.73M +11.6% Sep 30, 2025 10-Q 2025-11-13
Q2 2025 $83.1M +$12.7M +18% Jun 30, 2025 10-Q 2025-08-13
Q1 2025 $79.9M +$62.9M +372% Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $75.4M +$55.7M +282% Dec 31, 2024 10-Q 2025-11-13
Q3 2024 $75.5M +$75.5M Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $70.4M +$70.4M Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $16.9M Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $19.8M -$12.4M -38.6% Dec 31, 2023 10-K 2025-03-12
Q3 2023 $0 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $0 Jun 30, 2023 10-Q 2023-08-21
Q4 2022 $32.2M Dec 31, 2022 10-K 2024-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.